<--- Back to Details
First PageDocument Content
Oncology / Organochlorides / Phenols / Carcinogen / Carcinogenesis / Pentachlorophenol / Malathion / Toluidine / Medicine / Chemistry / Endocrine disruptors
Date: 2015-05-26 13:01:12
Oncology
Organochlorides
Phenols
Carcinogen
Carcinogenesis
Pentachlorophenol
Malathion
Toluidine
Medicine
Chemistry
Endocrine disruptors

Add to Reading List

Source URL: ntp.niehs.nih.gov

Download Document from Source Website

File Size: 38,48 KB

Share Document on Facebook

Similar Documents

Medical physics / Physics / Radiation therapy / Radiobiology / Medicine / Radiation / Fast neutron therapy / Neutron / Calibration / Dosimetry / Collimator

Clinical Neutron Therapy System Reference Manual Jonathan Jacky1 Ruedi Risler Radiation Oncology, Box

DocID: 1xVse - View Document

Humancomputer interaction / User interface techniques / Human behavior / Software architecture / Computing / Computer / User interface / Graphical user interface

Formal Development of a Graphical User Interface for a Radiation Therapy Machine Jonathan Jacky  Jonathan Unger Radiation Oncology Department RC-08 University of Washington

DocID: 1xViy - View Document

Health / Computing / Medical physics / Formal methods / Theoretical computer science / Therapy / Information and communications technology / Radiation therapy / Z notation / Computer / Software

Experience with Z Developing a Control Program for a Radiation Therapy Machine Jonathan Jacky , Jonathan Unger, Michael Patrick and Ruedi Risler Radiation Oncology Box

DocID: 1xV2d - View Document

Computing / Models of computation / Software engineering / Control engineering / Cognition / State / Control theory / Lookup table / Variable / Dependent and independent variables

Formal Speci cation and Development of Control System Input/Output Jonathan Jacky Radiation Oncology Department RC-08 University of Washington

DocID: 1xUvZ - View Document

Medicine / Clinical medicine / Cancer / Tyrosine kinase receptors / Breast cancer / Atezolizumab / ROS1 / Triple-negative breast cancer / Anaplastic lymphoma kinase / Trastuzumab emtansine / Entrectinib / Metastatic breast cancer

European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche Pharmaceuticals

DocID: 1xTgE - View Document